Ontario and other Canadian provinces are debating whether to hold back second doses or adopt a more flexible approach to vaccinate more people quickly. New modeling from the University of Toronto suggests that a single-dose strategy could prevent 34% of symptomatic infections. This shift in protocol during the rollout has led to questions about the consistency of the scientific guidance.




